Circulating Tumour Cells Technologies Shaping the Future of Oncology

According to a Research Report Published by Decisions Advisors and Consulting, The Global Circulating Tumour Cells Market Size was worth around USD 12.32 Billion in 2024 and is predicted to Grow to around USD 48.87 Billion by 2035 with a compound annual growth rate (CAGR) of 13.35% from 2025 to 2035. With the growth of technology and increased funding into R&D activities, there is a growing use of liquid biopsee technologies (such as CTCs) being implemented in healthcare, particularly in the hospital setting. In addition, as more genetic disorders are occurring as a result of lifestyle changes, the hospitals' liquid biopsy technology market will also continue to expand.According to a Research Report Published by Decisions Advisors and Consulting, The Global Circulating Tumour Cells Market Size was worth around USD 12.32 Billion in 2024 and is predicted to Grow to around USD 48.87 Billion by 2035 with a compound annual growth rate (CAGR) of 13.35% from 2025 to 2035. With the growth of technology and increased funding into R&D activities, there is a growing use of liquid biopsee technologies (such as CTCs) being implemented in healthcare, particularly in the hospital setting. In addition, as more genetic disorders are occurring as a result of lifestyle changes, the hospitals' liquid biopsy technology market will also continue to expand.